Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

The medical care of immunocompromised patients with COVID-19 infection causes major hurdles in the management of these patients in clinical practice. However, poor responses to vaccinations in patients with oncological or autoimmune diseases require rapid action and effective care in this fragile pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Klank, David, Claus, Bernd, Bergner, Raoul, Paschka, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786569/
https://www.ncbi.nlm.nih.gov/pubmed/36557743
http://dx.doi.org/10.3390/microorganisms10122490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786569/
https://www.ncbi.nlm.nih.gov/pubmed/36557743
http://dx.doi.org/10.3390/microorganisms10122490

Ejemplares similares